“Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.”
Backgrounds and aims: The role of hydroxychloroquine (HCQ) in the treatment of COVID-19 is not fully known. We studied the efficacy of HCQ compared to the control in COVID-19 subjects on - a. viral clearance measured by reverse transcriptase polymerase chain reaction (RT-PCR) and, b. death due to al...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12148
- Palabra clave:
- Hydroxychloroquine
COVID-19
Viral clearance
Outcomes
Death
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Acceso restringido
id |
UTADEO2_45b6d5a7a77522e1acad608cd12431f4 |
---|---|
oai_identifier_str |
oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12148 |
network_acronym_str |
UTADEO2 |
network_name_str |
Expeditio: repositorio UTadeo |
repository_id_str |
|
dc.title.spa.fl_str_mv |
“Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.” |
title |
“Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.” |
spellingShingle |
“Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.” Hydroxychloroquine COVID-19 Viral clearance Outcomes Death Síndrome respiratorio agudo grave COVID-19 SARS-CoV-2 Coronavirus |
title_short |
“Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.” |
title_full |
“Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.” |
title_fullStr |
“Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.” |
title_full_unstemmed |
“Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.” |
title_sort |
“Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.” |
dc.subject.spa.fl_str_mv |
Hydroxychloroquine COVID-19 Viral clearance Outcomes Death |
topic |
Hydroxychloroquine COVID-19 Viral clearance Outcomes Death Síndrome respiratorio agudo grave COVID-19 SARS-CoV-2 Coronavirus |
dc.subject.lemb.spa.fl_str_mv |
Síndrome respiratorio agudo grave COVID-19 SARS-CoV-2 Coronavirus |
description |
Backgrounds and aims: The role of hydroxychloroquine (HCQ) in the treatment of COVID-19 is not fully known. We studied the efficacy of HCQ compared to the control in COVID-19 subjects on - a. viral clearance measured by reverse transcriptase polymerase chain reaction (RT-PCR) and, b. death due to all cause. Methods: PubMed, Scopus, Cochrane and MedRxiv database were searched using the specific keywords up to April 30, 2020. Studies that met our objectives were assessed for the risk of bias applying various tools as indicated. Three studies each that reported the outcome of viral clearance by RT-PCR and death due to all cause, were meta-analyzed by applying inverse variance-weighted averages of logarithmic risk ratio (RR) using a random effects model. Heterogeneity and publication bias were assessed using the I 2 statistic and funnel plots, respectively. Results: Meta-analysis of 3 studies (n ¼ 210) on viral clearance assessed by RT-PCR showed no benefit (RR, 1.05; 95% CI, 0.79 to 1.38; p ¼ 0.74), although with a moderate heterogeneity (I2 ¼ 61.7%, p ¼ 0.07). While meta-analysis of 3 studies (n ¼ 474) showed a significant increase in death with HCQ, compared to the control (RR, 2.17; 95% 1.32 to 3.57; p ¼ 0.002), without any heterogeneity (I2 ¼ 0.0%, p ¼ 0.43). Conclusions: No benefit on viral clearance but a significant increase in mortality was observed with HCQ compared to control in patients with COVID-19. |
publishDate |
2020 |
dc.date.accessioned.none.fl_str_mv |
2020-08-24T15:50:41Z |
dc.date.available.none.fl_str_mv |
2020-08-24T15:50:41Z |
dc.date.created.none.fl_str_mv |
2020 |
dc.type.local.spa.fl_str_mv |
Artículo |
dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
format |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.identifier.issn.spa.fl_str_mv |
1871-4021 |
dc.identifier.other.spa.fl_str_mv |
https://doi.org/10.1016/j.dsx.2020.05.017 |
dc.identifier.uri.none.fl_str_mv |
http://hdl.handle.net/20.500.12010/12148 |
dc.identifier.doi.spa.fl_str_mv |
https://doi.org/10.1016/j.dsx.2020.05.017 |
identifier_str_mv |
1871-4021 |
url |
https://doi.org/10.1016/j.dsx.2020.05.017 http://hdl.handle.net/20.500.12010/12148 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_f1cf |
dc.rights.local.spa.fl_str_mv |
Acceso restringido |
rights_invalid_str_mv |
Acceso restringido http://purl.org/coar/access_right/c_f1cf |
dc.format.extent.spa.fl_str_mv |
8 páginas |
dc.format.mimetype.spa.fl_str_mv |
image/jepg |
dc.publisher.spa.fl_str_mv |
Diabetes & Metabolic Syndrome: Clinical Research & Reviews |
dc.source.spa.fl_str_mv |
reponame:Expeditio Repositorio Institucional UJTL instname:Universidad de Bogotá Jorge Tadeo Lozano |
instname_str |
Universidad de Bogotá Jorge Tadeo Lozano |
institution |
Universidad de Bogotá Jorge Tadeo Lozano |
reponame_str |
Expeditio Repositorio Institucional UJTL |
collection |
Expeditio Repositorio Institucional UJTL |
bitstream.url.fl_str_mv |
https://expeditiorepositorio.utadeo.edu.co/bitstream/20.500.12010/12148/1/Captura.PNG https://expeditiorepositorio.utadeo.edu.co/bitstream/20.500.12010/12148/3/-Hydroxychloroquine-in-patients-with-COVID_2020_Diabetes---Metabolic-Syndrom.pdf https://expeditiorepositorio.utadeo.edu.co/bitstream/20.500.12010/12148/2/license.txt https://expeditiorepositorio.utadeo.edu.co/bitstream/20.500.12010/12148/4/Captura.PNG https://expeditiorepositorio.utadeo.edu.co/bitstream/20.500.12010/12148/5/-Hydroxychloroquine-in-patients-with-COVID_2020_Diabetes---Metabolic-Syndrom.pdf.jpg |
bitstream.checksum.fl_str_mv |
143dfdd342e7fdf07b4e3fa34a270df2 8298c93dae50e65a48ea05e8cd2bf0a6 abceeb1c943c50d3343516f9dbfc110f 143dfdd342e7fdf07b4e3fa34a270df2 3bec75382606c8333a3c1eab87de1dea |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Institucional - Universidad Jorge Tadeo Lozano |
repository.mail.fl_str_mv |
expeditio@utadeo.edu.co |
_version_ |
1814213533394534400 |
spelling |
2020-08-24T15:50:41Z2020-08-24T15:50:41Z20201871-4021https://doi.org/10.1016/j.dsx.2020.05.017http://hdl.handle.net/20.500.12010/12148https://doi.org/10.1016/j.dsx.2020.05.017Backgrounds and aims: The role of hydroxychloroquine (HCQ) in the treatment of COVID-19 is not fully known. We studied the efficacy of HCQ compared to the control in COVID-19 subjects on - a. viral clearance measured by reverse transcriptase polymerase chain reaction (RT-PCR) and, b. death due to all cause. Methods: PubMed, Scopus, Cochrane and MedRxiv database were searched using the specific keywords up to April 30, 2020. Studies that met our objectives were assessed for the risk of bias applying various tools as indicated. Three studies each that reported the outcome of viral clearance by RT-PCR and death due to all cause, were meta-analyzed by applying inverse variance-weighted averages of logarithmic risk ratio (RR) using a random effects model. Heterogeneity and publication bias were assessed using the I 2 statistic and funnel plots, respectively. Results: Meta-analysis of 3 studies (n ¼ 210) on viral clearance assessed by RT-PCR showed no benefit (RR, 1.05; 95% CI, 0.79 to 1.38; p ¼ 0.74), although with a moderate heterogeneity (I2 ¼ 61.7%, p ¼ 0.07). While meta-analysis of 3 studies (n ¼ 474) showed a significant increase in death with HCQ, compared to the control (RR, 2.17; 95% 1.32 to 3.57; p ¼ 0.002), without any heterogeneity (I2 ¼ 0.0%, p ¼ 0.43). Conclusions: No benefit on viral clearance but a significant increase in mortality was observed with HCQ compared to control in patients with COVID-19.8 páginasimage/jepgengDiabetes & Metabolic Syndrome: Clinical Research & Reviewsreponame:Expeditio Repositorio Institucional UJTLinstname:Universidad de Bogotá Jorge Tadeo LozanoHydroxychloroquineCOVID-19Viral clearanceOutcomesDeathSíndrome respiratorio agudo graveCOVID-19SARS-CoV-2Coronavirus“Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.”Artículohttp://purl.org/coar/resource_type/c_2df8fbb1Acceso restringidohttp://purl.org/coar/access_right/c_f1cfKumar Singh, AwadheshSingh, AkritiSingh, RituMisra, AnoopORIGINALCaptura.PNGCaptura.PNGVer portadaimage/png190186https://expeditiorepositorio.utadeo.edu.co/bitstream/20.500.12010/12148/1/Captura.PNG143dfdd342e7fdf07b4e3fa34a270df2MD51open access-Hydroxychloroquine-in-patients-with-COVID_2020_Diabetes---Metabolic-Syndrom.pdf-Hydroxychloroquine-in-patients-with-COVID_2020_Diabetes---Metabolic-Syndrom.pdfArtículo reservadoapplication/pdf785405https://expeditiorepositorio.utadeo.edu.co/bitstream/20.500.12010/12148/3/-Hydroxychloroquine-in-patients-with-COVID_2020_Diabetes---Metabolic-Syndrom.pdf8298c93dae50e65a48ea05e8cd2bf0a6MD53embargoed access|||2200-08-24LICENSElicense.txtlicense.txttext/plain; charset=utf-82938https://expeditiorepositorio.utadeo.edu.co/bitstream/20.500.12010/12148/2/license.txtabceeb1c943c50d3343516f9dbfc110fMD52open accessTHUMBNAILCaptura.PNGCaptura.PNGPortadaimage/png190186https://expeditiorepositorio.utadeo.edu.co/bitstream/20.500.12010/12148/4/Captura.PNG143dfdd342e7fdf07b4e3fa34a270df2MD54open access-Hydroxychloroquine-in-patients-with-COVID_2020_Diabetes---Metabolic-Syndrom.pdf.jpg-Hydroxychloroquine-in-patients-with-COVID_2020_Diabetes---Metabolic-Syndrom.pdf.jpgIM Thumbnailimage/jpeg15141https://expeditiorepositorio.utadeo.edu.co/bitstream/20.500.12010/12148/5/-Hydroxychloroquine-in-patients-with-COVID_2020_Diabetes---Metabolic-Syndrom.pdf.jpg3bec75382606c8333a3c1eab87de1deaMD55open access20.500.12010/12148oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/121482020-08-24 10:50:41.485open accessRepositorio Institucional - Universidad Jorge Tadeo Lozanoexpeditio@utadeo.edu.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 |